Ryan Mitchell - Satellos Bioscience Vice Development
| MSCL Stock | 0.84 0.01 1.20% |
Executive
Ryan Mitchell is Vice Development of Satellos Bioscience
| Phone | 647-660-1780 |
| Web | https://satellos.com |
Satellos Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.5425) % which means that it has lost $0.5425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8759) %, meaning that it generated substantial loss on money invested by shareholders. Satellos Bioscience's management efficiency ratios could be used to measure how well Satellos Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Christopher Barnes | Sernova Corp | N/A | |
| Alfred DSouza | Biosyent | N/A | |
| Patrick Gamble | Quipt Home Medical | 62 | |
| Christof Boehler | Helix BioPharma Corp | N/A | |
| Modestus MBA | Sernova Corp | N/A | |
| MAcc CPACA | Sernova Corp | 61 | |
| Joost Mark | Biosyent | N/A | |
| Nick Dam | Cannara Biotech | N/A | |
| David Burke | Sernova Corp | N/A | |
| Andrew MD | Cardiol Therapeutics Class | 64 | |
| William Zehnder | Quipt Home Medical | 51 | |
| Helen Middleton | Helix BioPharma Corp | N/A | |
| Kevin Wilson | Biosyent | N/A | |
| Veronika Kandziora | Helix BioPharma Corp | N/A | |
| Etienne Ledoux | Cannara Biotech | N/A | |
| France Landry | Cannara Biotech | N/A | |
| Namrata Malhotra | Helix BioPharma Corp | N/A | |
| MD FCAP | Medicenna Therapeutics Corp | N/A | |
| Thomas MD | Helix BioPharma Corp | N/A | |
| Hardik Mehta | Quipt Home Medical | 44 | |
| Cole Stevens | Quipt Home Medical | N/A | |
Management Performance
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.54 |
Satellos Bioscience Leadership Team
Elected by the shareholders, the Satellos Bioscience's board of directors comprises two types of representatives: Satellos Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Satellos. The board's role is to monitor Satellos Bioscience's management team and ensure that shareholders' interests are well served. Satellos Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Satellos Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA, Chief Officer | ||
| Philip MA, Chief Officer | ||
| CPA CMA, Head Strategy | ||
| Francis MBA, CEO, CoFounder | ||
| Ryan Mitchell, Vice Development | ||
| Desiree Chan, Chief Staff | ||
| William Jarosz, Executive Director | ||
| Courtney Wells, Senior Operations | ||
| Jordan MD, Chair Officer | ||
| Michael Rudnicki, CoFounder Officer | ||
| Robert CFA, Senior Administration | ||
| Bsc BSc, Strategic Advisor | ||
| MPH MD, Chief Officer |
Satellos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Satellos Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.88 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 106 M | ||||
| Shares Outstanding | 185.51 M | ||||
| Shares Owned By Insiders | 8.30 % | ||||
| Shares Owned By Institutions | 8.20 % | ||||
| Number Of Shares Shorted | 245.57 K | ||||
| Price To Book | 3.27 X | ||||
| Gross Profit | (16.68 M) | ||||
| EBITDA | (28.08 M) |
Pair Trading with Satellos Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Satellos Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Satellos Bioscience will appreciate offsetting losses from the drop in the long position's value.Moving together with Satellos Stock
Moving against Satellos Stock
| 0.58 | CM | Canadian Imperial Bank | PairCorr |
| 0.49 | RY | Royal Bank | PairCorr |
| 0.47 | AX-UN | Artis Real Estate | PairCorr |
| 0.46 | APS | Aptose Biosciences | PairCorr |
| 0.44 | TD-PFI | Toronto Dominion Bank | PairCorr |
The ability to find closely correlated positions to Satellos Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Satellos Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Satellos Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Satellos Bioscience to buy it.
The correlation of Satellos Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Satellos Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Satellos Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Satellos Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.